LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 87.86 | 84.90 | 1140 | 7680 | 0.1484 | 0.4913 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 87.86 | 84.90 | 1163 | 7680 | 0.1514 | 0.4959 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 87.86 | 84.90 | 112 | 7680 | 0.0146 | 0.0436 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 87.86 | 84.90 | 1357 | 7680 | 0.1767 | 0.5318 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 89.57 | 84.90 | 1149 | 7494 | 0.1533 | 0.4964 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 89.57 | 84.90 | 1169 | 7494 | 0.1560 | 0.5004 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 89.57 | 84.90 | 107 | 7494 | 0.0143 | 0.0364 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 89.57 | 84.90 | 1421 | 7494 | 0.1896 | 0.5464 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 91.27 | 84.90 | 1156 | 7420 | 0.1558 | 0.4991 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 91.27 | 84.90 | 1188 | 7420 | 0.1601 | 0.5055 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 91.27 | 84.90 | 102 | 7420 | 0.0137 | 0.0289 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 91.27 | 84.90 | 1333 | 7420 | 0.1796 | 0.5326 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 92.98 | 84.90 | 1137 | 7257 | 0.1567 | 0.4983 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 92.98 | 84.90 | 1178 | 7257 | 0.1623 | 0.5066 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 92.98 | 84.90 | 109 | 7257 | 0.0150 | 0.0397 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 92.98 | 84.90 | 1346 | 7257 | 0.1855 | 0.5382 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 94.68 | 84.90 | 1050 | 7000 | 0.1500 | 0.4846 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 94.68 | 84.90 | 1170 | 7000 | 0.1671 | 0.5100 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 94.68 | 84.90 | 101 | 7000 | 0.0144 | 0.0277 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 94.68 | 84.90 | 1399 | 7000 | 0.1999 | 0.5530 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 2.66 | 84.90 | 536 | 285 | 1.8758 | 1.8646 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 2.66 | 84.90 | 8 | 285 | 0.0280 | -0.7405 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 2.66 | 84.90 | 337 | 285 | 1.1794 | 1.1976 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | D08 |